Lovely Meds provides GLP-1 and other medications through licensed U.S. pharmacies. Compounded medications, including semaglutide and tirzepatide, are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound™ (tirzepatide) are FDA-approved; however, compounded versions may be prescribed by independent licensed physicians when clinically appropriate, such as during FDA-declared shortages or to meet specific patient needs.

All prescription products require an online evaluation by an independent licensed medical professional, who will determine if treatment is appropriate. Prescriptions are filled by partner pharmacies unless you request an alternative, and product packaging may differ from images shown.

Compounded medications are custom preparations made by state-licensed pharmacies. They are not manufactured or endorsed by the original brand manufacturer and may differ in form, strength, or appearance. These products are dispensed under U.S. state pharmacy laws and in accordance with FDA guidance where applicable. Patients should carefully review potential risks, benefits, and alternatives with their prescribing clinician before use.

By using Lovely Meds services, you consent to the limited use of de-identified data for advertising purposes on platforms such as Google and Facebook to reach new patients or exclude existing ones. You may opt out of marketing emails at any time by using the unsubscribe link provided or by contacting us directly at hello@lovelymeds.com.